Cargando…

Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats

Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Alaa, Habiba, Abdelaziz, Mariam, Mustafa, Maryam, Mansour, Mustafa, Magdy, Salma, Mohsen, Salma, El-Karamany, Yomna, Farid, Alyaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313733/
https://www.ncbi.nlm.nih.gov/pubmed/37391460
http://dx.doi.org/10.1038/s41598-023-36929-0
_version_ 1785067179091165184
author Alaa, Habiba
Abdelaziz, Mariam
Mustafa, Maryam
Mansour, Mustafa
Magdy, Salma
Mohsen, Salma
El-Karamany, Yomna
Farid, Alyaa
author_facet Alaa, Habiba
Abdelaziz, Mariam
Mustafa, Maryam
Mansour, Mustafa
Magdy, Salma
Mohsen, Salma
El-Karamany, Yomna
Farid, Alyaa
author_sort Alaa, Habiba
collection PubMed
description Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fact that melatonin is quickly transported through the mucosa, its sensitivity to be oxidized creates a difficulty in achieving the required dose. Additionally, due to its variable absorption and poor oral bioavailability necessitates the development of alternative delivery methods. The study aimed to synthesize melatonin loaded chitosan/lecithin (Mel-C/L) nanoparticles to be assessed in the treatment of streptozotocin (STZ)-induced diabetes in rats. The antioxidant, anti-inflammatory, and cytotoxicity properties of nanoparticles were estimated to determine the safety of manufactured nanoparticles for in vivo studies. In addition, Mel-C/L nanoparticles were administered to rats for eight weeks after inducing hyperglycemia. The therapeutic effect of Mel-C/L nanoparticles was assessed in all experimental groups by detecting insulin and blood glucose levels; observing improvements in liver and kidney functions as well as histological and immunohistochemical evaluation of rats’ pancreatic sections. The results proved that Mel-C/L nanoparticles showed remarkable anti-inflammatory, anti-coagulant, and anti-oxidant effects, in addition to its efficiency in reducing blood glucose levels of STZ-induced diabetic rats and great ability to promote the regeneration of pancreatic beta (β)-cells. Furthermore, Mel-C/L nanoparticles elevated the insulin level; and decreased the elevated levels of urea, creatinine and cholesterol. In conclusion, nanoparticles application decreased the administrated melatonin dose that in turn can diminish the side effects of free melatonin administration.
format Online
Article
Text
id pubmed-10313733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103137332023-07-02 Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats Alaa, Habiba Abdelaziz, Mariam Mustafa, Maryam Mansour, Mustafa Magdy, Salma Mohsen, Salma El-Karamany, Yomna Farid, Alyaa Sci Rep Article Nanotechnology is used to overcome fundamental flaws in today's marketed pharmaceuticals that obstruct therapy, like restricted solubility and quick release of drugs into the bloodstream. In both human and animal researches, melatonin was demonstrated to regulate glucose levels. Despite the fact that melatonin is quickly transported through the mucosa, its sensitivity to be oxidized creates a difficulty in achieving the required dose. Additionally, due to its variable absorption and poor oral bioavailability necessitates the development of alternative delivery methods. The study aimed to synthesize melatonin loaded chitosan/lecithin (Mel-C/L) nanoparticles to be assessed in the treatment of streptozotocin (STZ)-induced diabetes in rats. The antioxidant, anti-inflammatory, and cytotoxicity properties of nanoparticles were estimated to determine the safety of manufactured nanoparticles for in vivo studies. In addition, Mel-C/L nanoparticles were administered to rats for eight weeks after inducing hyperglycemia. The therapeutic effect of Mel-C/L nanoparticles was assessed in all experimental groups by detecting insulin and blood glucose levels; observing improvements in liver and kidney functions as well as histological and immunohistochemical evaluation of rats’ pancreatic sections. The results proved that Mel-C/L nanoparticles showed remarkable anti-inflammatory, anti-coagulant, and anti-oxidant effects, in addition to its efficiency in reducing blood glucose levels of STZ-induced diabetic rats and great ability to promote the regeneration of pancreatic beta (β)-cells. Furthermore, Mel-C/L nanoparticles elevated the insulin level; and decreased the elevated levels of urea, creatinine and cholesterol. In conclusion, nanoparticles application decreased the administrated melatonin dose that in turn can diminish the side effects of free melatonin administration. Nature Publishing Group UK 2023-06-30 /pmc/articles/PMC10313733/ /pubmed/37391460 http://dx.doi.org/10.1038/s41598-023-36929-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Alaa, Habiba
Abdelaziz, Mariam
Mustafa, Maryam
Mansour, Mustafa
Magdy, Salma
Mohsen, Salma
El-Karamany, Yomna
Farid, Alyaa
Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title_full Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title_fullStr Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title_full_unstemmed Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title_short Therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
title_sort therapeutic effect of melatonin-loaded chitosan/lecithin nanoparticles on hyperglycemia and pancreatic beta cells regeneration in streptozotocin-induced diabetic rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313733/
https://www.ncbi.nlm.nih.gov/pubmed/37391460
http://dx.doi.org/10.1038/s41598-023-36929-0
work_keys_str_mv AT alaahabiba therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT abdelazizmariam therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT mustafamaryam therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT mansourmustafa therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT magdysalma therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT mohsensalma therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT elkaramanyyomna therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats
AT faridalyaa therapeuticeffectofmelatoninloadedchitosanlecithinnanoparticlesonhyperglycemiaandpancreaticbetacellsregenerationinstreptozotocininduceddiabeticrats